Filing Details

Accession Number:
0001209191-17-065973
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-15 16:47:00
Reporting Period:
2017-12-13
Accepted Time:
2017-12-15 16:47:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278710 Robert Coffman C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-13 7,500 $5.40 13,808 No 4 M Direct
Common Stock Disposition 2017-12-13 7,500 $18.90 6,308 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-12-13 7,500 $0.00 7,500 $5.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-09 No 4 M Direct
Footnotes
  1. Includes 1,561 shares obtained upon the vesting of an RSU on February 5, 2015
  2. Option is fully-vested and exercisable